Use of pegylated Type III Interferons for the treatment of hepatitis C

Details for Australian Patent Application No. 2009255994 (hide)

Owner ZymoGenetics, LLC Bristol-Myers Squibb Company

Inventors Dodds, Michael G.; Hausman, Diana F.

Agent Griffith Hack

Pub. Number AU-A-2009255994

PCT Pub. Number WO2009/149377

Priority 61/059,237 05.06.08 US; 61/109,455 29.10.08 US; 61/167,763 08.04.09 US

Filing date 5 June 2009

Wipo publication date 10 December 2009

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2009/149377 Priority application(s): WO2009/149377

17 February 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Jan 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009255999-Anti-CD8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory CD8+T cells

2009255992-Plug assembly with plug head attachment